DaVita studies suggest expanded hemodialysis preserves albumin levels

By Public Technologies
  • DaVita will present seven studies at American Society of Nephrology Kidney Week 2026, with presentations scheduled for Oct. 22-24.
  • Two expanded hemodialysis studies suggest the therapy could benefit a broad patient population while preserving albumin levels.
  • A peritoneal dialysis study links treatment completion following hospital discharge to reduced cumulative hospitalizations.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DaVita Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610150900PR_NEWS_USPR_____LA72930) on October 15, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk